Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL124244 | 0.85 | — | — | |
| SCHEMBL233605 | 0.85 | ALDH1A1 (0.31) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| Water SCHEMBL11545902 | 0.84 | — | — | |
| SCHEMBL8735309 | 0.84 | — | — | |
| SCHEMBL5580135 | 0.83 | ALDH1A1 (0.33) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL8989385 | 0.81 | — | — | |
| Nitrilotriacetic Acid SCHEMBL7616551 | 0.81 | TDP1 (0.32) | LMNATDP1 | |
| Edetic Acid SCHEMBL3865960 | 0.79 | TDP1 (0.42) | LMNATDP1 | |
| Pentetic Acid SCHEMBL8656975 | 0.77 | TDP1 (0.44) | LMNAMAPTTDP1 | |
| SCHEMBL9771357 | 0.77 | TDP1 (0.37) | LMNAMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2155162-B1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB (US) | 2012-11-21 | — | — | EP | claimed |
| EP-2155162-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | Bausch & Lomb Incorporated (US) | 2010-02-24 | — | — | EP | claimed |
| WO-2008137496-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB INCORPORATED (US) | 2008-11-13 | — | — | WO | claimed |
| US-20080275000-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | SALIX PHARMACEUTICALS, INC. | 2008-11-06 | — | — | US | claimed |
| CN-110073051-B | Method for treating fiber product | 花王株式会社 | 2021-12-24 | — | — | CN | disclosed |
| CN-109863269-B | Finishing agent composition for fiber product | 花王株式会社 | 2021-11-19 | — | — | CN | disclosed |
| EP-3561175-A1 | METHOD FOR PROCESSING FIBER PRODUCT | Kao Corporation (JP) | 2019-10-30 | — | — | EP | disclosed |
| EP-3467081-A1 | DETERGENT COMPOSITION FOR FIBRES | Kao Corporation (JP) | 2019-04-10 | — | — | EP | disclosed |
| US-8415342-B2 | Besifloxacin ophthalmic composition for the treatment or control of infection | BAUSCH & LOMB INCORPORATED (US) | 2013-04-09 | — | — | US | disclosed |
| EP-2155162-B1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB (US) | 2012-11-21 | — | — | EP | disclosed |
| WO-2010051291-A1 | BESIFLOXACIN OPHTHALMIC COMPOSITION FOR THE TREATMENT OR CONTROL OF INFECTION | BAUSCH & LOMB INCORPORATED (US) | 2010-05-06 | — | — | WO | disclosed |
| US-20100105662-A1 | Besifloxacin Ophthalmic Composition for the Treatment or Control of Infection | MEDICIS PHARMACEUTICAL CORPORATION | 2010-04-29 | — | — | US | disclosed |
| EP-2155162-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | Bausch & Lomb Incorporated (US) | 2010-02-24 | — | — | EP | disclosed |
| US-20080280853-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB INCORPORATED | 2008-11-13 | — | — | US | disclosed |
| WO-2008137826-A2 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB INCORPORATED (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008137496-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB INCORPORATED (US) | 2008-11-13 | — | — | WO | disclosed |
| US-20080275000-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | SALIX PHARMACEUTICALS, INC. | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275000-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | PDE6D, PDE6H, CA2 | ALDH1A1 993/4885LMNA 3687/4885MAPT 4239/4885 |
| US-20080280853-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | CA2, IDUA, CA6 | ALDH1A1 633/4885LMNA 3568/4885MAPT 3870/4885 |
| US-20100105662-A1 | Besifloxacin Ophthalmic Composition for the Treatment or Control of Infection | BLM, BROX, CRYAB | ALDH1A1 4717/4885LMNA 3732/4885MAPT 561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.